Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 2476 AL 2490

Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis

Mulligan VK, Chakrabartty A.

Proteins. 2013 Aug;81(8):1285-303. doi: 10.1002/prot.24285. Epub 2013 Jul 2.

Corticostriatal connectivity and its role in disease

Shepherd GM.

Nat Rev Neurosci. 2013 Apr;14(4):278-91. doi: 10.1038/nrn3469.

RNA toxicity in polyglutamine disorders: concepts, models, and progress of research

Fiszer A, Krzyzosiak WJ.

J Mol Med (Berl). 2013 Jun;91(6):683-91. doi: 10.1007/s00109-013-1016-2. Epub 2013 Mar 20.

VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair

Waschek JA.

Br J Pharmacol. 2013 Jun;169(3):512-23. doi: 10.1111/bph.12181.

Reliability and minimal detectable change of physical performance measures in individuals with pre-manifest and manifest Huntington disease

Quinn L, Khalil H, Dawes H, Fritz NE, Kegelmeyer D, Kloos AD, Gillard JW, Busse M; Outcome Measures Subgroup of the European Huntington's Disease Network.

Phys Ther. 2013 Jul;93(7):942-56. doi: 10.2522/ptj.20130032. Epub 2013 Mar 21.

Movement disorders in multiple sclerosis and other demyelinating diseases

Mehanna R, Jankovic J.

J Neurol Sci. 2013 May 15;328(1-2):1-8. doi: 10.1016/j.jns.2013.02.007. Epub 2013 Mar 19.

Genomics in cardiovascular disease

Roberts R, Marian AJ, Dandona S, Stewart AF.

J Am Coll Cardiol. 2013 May 21;61(20):2029-37. doi: 10.1016/j.jacc.2012.12.054. Epub 2013 Mar 21.

[A case of subacute parkinsonism presenting as bilateral basal ganglia legions by MRI in diabetic uremic syndrome]

Nishimura Y, Shibata K, Funaki T, Ito H, Ito E, Otsuka K.

Rinsho Shinkeigaku. 2013;53(3):217-23. doi: 10.5692/clinicalneurol.53.217.

Altered Fractional Anisotropy in Early Huntington's Disease

Singh S, Mehta H, Fekete R.

Case Rep Neurol. 2013 Jan;5(1):26-30. doi: 10.1159/000348399. Epub 2013 Feb 16.

The role of amyloidogenic protein oligomerization in neurodegenerative disease

Lotz GP, Legleiter J.

J Mol Med (Berl). 2013 Jun;91(6):653-64. doi: 10.1007/s00109-013-1025-1. Epub 2013 Mar 27.

Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases

van der Putten H, Lotz GP.

Neurotherapeutics. 2013 Jul;10(3):416-28. doi: 10.1007/s13311-013-0186-5.

Huntington's disease gene expansion associates with early onset nonprogressive chorea

Dosa L, Malandrini A, Di Donato I, Hladnik U, Meloni I, Mari F, Federico A.

Mov Disord. 2013 May;28(5):684. doi: 10.1002/mds.25443. Epub 2013 Mar 27.

Primary antiphospholipid syndrome manifesting as partial status epilepticus

Maalouf NN, Hinduja A, Shihabuddin BS.

Neurosciences (Riyadh). 2013 Apr;18(2):160-2.

Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases

Natale G, Pompili E, Biagioni F, Paparelli S, Lenzi P, Fornai F.

Eur J Histochem. 2013 Mar 7;57(1):e5. doi: 10.4081/ejh.2013.e5.

Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression

Leoni V, Long JD, Mills JA, Di Donato S, Paulsen JS; PREDICT-HD study group.

Neurobiol Dis. 2013 Jul;55:37-43. doi: 10.1016/j.nbd.2013.03.013. Epub 2013 Apr 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias